Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

52.68
+0.59001.13%
Volume:979.94K
Turnover:51.50M
Market Cap:3.76B
PE:-44.81
High:53.57
Open:52.14
Low:51.45
Close:52.09
52wk High:54.39
52wk Low:12.56
Shares:71.32M
Float Shares:20.81M
Volume Ratio:1.89
T/O Rate:4.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1756
EPS(LYR):-1.0800
ROE:-78.49%
ROA:-44.34%
PB:37.76
PE(LYR):-48.78

Loading ...

Pulse Biosciences Q1 EPS USD -0.27

THOMSON REUTERS
·
May 04

Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data

TIPRANKS
·
Apr 27

Pulse Biosciences reports 96% one-year success in nPulse AF catheter study

Reuters
·
Apr 27

Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System

TIPRANKS
·
Apr 27

BRIEF-Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System

Reuters
·
Apr 26

Pulse Biosciences nPulse catheter posts 96% AF ablation success at one year

Reuters
·
Apr 26

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

TIPRANKS
·
Apr 20

Pulse Biosciences to present one-year nsPFA atrial fibrillation study outcomes at HRS 2026

Reuters
·
Apr 20

Pulse Biosciences to host analyst event after Heart Rhythm Society late-breaking data presentation

Reuters
·
Apr 17

Pulse Biosciences Targets Thyroid Nodules With New Device Study, Eyeing a Minimally Invasive Niche

TIPRANKS
·
Apr 17

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy

TIPRANKS
·
Apr 16

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story?

Simply Wall St.
·
Apr 12

BRIEF-Pulse Biosciences Strengthens Executive Leadership Team

Reuters
·
Apr 09

Pulse Biosciences names Liane Teplitsky chief operating officer

Reuters
·
Apr 09

Affluent Medical names Anne Lange to board, replaces Soad El Gazaoui

Reuters
·
Apr 09

Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study

TIPRANKS
·
Apr 07

Pulse Biosciences enrolls first patients in NANOPULSE-AF pivotal trial for AF ablation system

Reuters
·
Apr 07

Pulse Biosciences Enrolls First Patients in Nanopulse-Af Ide Pivotal Clinical Study Evaluating Npulse™ Cardiac Catheter System for Atrial Fibrillation

THOMSON REUTERS
·
Apr 07

Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge?

Simply Wall St.
·
Apr 03

Pulse Biosciences to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 03